297 related articles for article (PubMed ID: 10987278)
21. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
[TBL] [Abstract][Full Text] [Related]
22. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
Lin L; Aggarwal S; Glover TW; Orringer MB; Hanash S; Beer DG
Cancer Res; 2000 Mar; 60(5):1341-7. PubMed ID: 10728696
[TBL] [Abstract][Full Text] [Related]
23. Defining a common region of DNA amplification at 22q11.2-12 in head and neck squamous cell carcinomas by quantitative FISH analysis.
Matsumura K; Iritani A; Enomoto S; Torikata C; Matsuyama S; Kurita A; Kurahashi H; Tsuchida N
Genes Chromosomes Cancer; 2000 Nov; 29(3):207-12. PubMed ID: 10992295
[TBL] [Abstract][Full Text] [Related]
24. Amplification and expression of the human cyclin D gene in esophageal cancer.
Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB
Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
[TBL] [Abstract][Full Text] [Related]
26. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
27. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
28. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
[TBL] [Abstract][Full Text] [Related]
29. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
Imoto I; Yang ZQ; Pimkhaokham A; Tsuda H; Shimada Y; Imamura M; Ohki M; Inazawa J
Cancer Res; 2001 Sep; 61(18):6629-34. PubMed ID: 11559525
[TBL] [Abstract][Full Text] [Related]
30. Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
Obara K; Ghazizadeh M; Shimizu H; Arai R; Tenjin T; Suzuki S; Moriyama Y; Kawanami O
Int J Oncol; 2002 Feb; 20(2):255-60. PubMed ID: 11788885
[TBL] [Abstract][Full Text] [Related]
31. MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
[TBL] [Abstract][Full Text] [Related]
32. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.
Sen S; Zhou H; White RA
Oncogene; 1997 May; 14(18):2195-200. PubMed ID: 9174055
[TBL] [Abstract][Full Text] [Related]
33. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
[TBL] [Abstract][Full Text] [Related]
34. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
35. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma.
Yang SB; Zhou XB; Zhu HX; Quan LP; Bai JF; He J; Gao YN; Cheng SJ; Xu NZ
Oncol Rep; 2007 May; 17(5):1083-8. PubMed ID: 17390048
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
Sugimoto T; Arai M; Shimada H; Hata A; Seki N
Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
[TBL] [Abstract][Full Text] [Related]
37. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
[TBL] [Abstract][Full Text] [Related]
38. Novel human esophagus-specific gene c1orf10: cDNA cloning, gene structure, and frequent loss of expression in esophageal cancer.
Xu Z; Wang MR; Xu X; Cai Y; Han YL; Wu KM; Wang J; Chen BS; Wang XQ; Wu M
Genomics; 2000 Nov; 69(3):322-30. PubMed ID: 11056050
[TBL] [Abstract][Full Text] [Related]
39. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
40. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
Liu G; Bollig-Fischer A; Kreike B; van de Vijver MJ; Abrams J; Ethier SP; Yang ZQ
Oncogene; 2009 Dec; 28(50):4491-500. PubMed ID: 19784073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
